Terzic, J., Seipel, A., Dubuisson, J., Tille, J., Tsantoulis, P., Addeo, A., & Labidi-Galy, S. (2020). Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation. Gynecol Oncol Rep.

Terzic, Julie, Amanda Seipel, Jean Dubuisson, Jean-Christophe Tille, Petros Tsantoulis, Alfredo Addeo, und S.Intidhar Labidi-Galy. "Sustained Response to Pembrolizumab Without Prior Chemotherapy in High-grade Serous Ovarian Carcinoma With CSMD3 Mutation." Gynecol Oncol Rep 2020.

Terzic, Julie, et al. "Sustained Response to Pembrolizumab Without Prior Chemotherapy in High-grade Serous Ovarian Carcinoma With CSMD3 Mutation." Gynecol Oncol Rep 2020.